Integer Holdings Corporation (NYSE:ITGR - Get Free Report)'s stock price hit a new 52-week low during trading on Wednesday . The company traded as low as $103.60 and last traded at $103.29, with a volume of 24091 shares changing hands. The stock had previously closed at $105.52.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on ITGR shares. Truist Financial reduced their price objective on shares of Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a report on Friday, July 25th. Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and raised their target price for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Raymond James Financial lowered their price target on Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a report on Friday, July 25th. Wells Fargo & Company cut their price objective on shares of Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a report on Friday, July 25th. Finally, Wall Street Zen upgraded shares of Integer from a "hold" rating to a "buy" rating in a research note on Saturday, August 30th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, Integer has an average rating of "Buy" and an average price target of $140.25.
View Our Latest Analysis on ITGR
Integer Price Performance
The company has a 50 day moving average price of $110.63 and a 200 day moving average price of $116.39. The company has a debt-to-equity ratio of 0.72, a current ratio of 3.41 and a quick ratio of 2.18. The firm has a market cap of $3.60 billion, a PE ratio of 45.35, a PEG ratio of 0.84 and a beta of 1.03.
Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). The firm had revenue of $476.00 million for the quarter, compared to analysts' expectations of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.The firm's quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. Sell-side analysts expect that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.
Institutional Investors Weigh In On Integer
Several institutional investors have recently modified their holdings of the company. Deutsche Bank AG grew its stake in Integer by 49.8% in the 4th quarter. Deutsche Bank AG now owns 29,381 shares of the medical equipment provider's stock valued at $3,894,000 after acquiring an additional 9,770 shares during the last quarter. D. E. Shaw & Co. Inc. raised its position in shares of Integer by 33.4% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 9,516 shares of the medical equipment provider's stock worth $1,261,000 after purchasing an additional 2,384 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Integer by 3.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,678 shares of the medical equipment provider's stock valued at $2,740,000 after buying an additional 685 shares in the last quarter. ProShare Advisors LLC increased its position in Integer by 44.4% during the fourth quarter. ProShare Advisors LLC now owns 10,051 shares of the medical equipment provider's stock worth $1,332,000 after buying an additional 3,091 shares in the last quarter. Finally, Teza Capital Management LLC raised its holdings in shares of Integer by 11.6% in the fourth quarter. Teza Capital Management LLC now owns 2,727 shares of the medical equipment provider's stock worth $361,000 after acquiring an additional 284 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.
Integer Company Profile
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.